SiRNA therapy for transthyretin (TTR) related ocular amyloidosis

Details for Australian Patent Application No. 2011235276 (hide)

Owner Jono, H. Kumamoto University Alnylam Pharmaceuticals, Inc. Ando, Y.

Inventors Ando, Yukio; Jono, Hirofumi; Alvarez, Rene; Sah, Dinah Wen-Yee

Agent FB Rice

Pub. Number AU-A-2011235276

PCT Pub. Number WO2011/123468

Priority 61/318,702 29.03.10 US; 61/318,704 29.03.10 US

Filing date 29 March 2011

Wipo publication date 6 October 2011

International Classifications

A61K 31/7088 - Compounds having three or more nucleosides or nucleotides

C07H 21/02 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Event Publications

20 September 2012 PCT application entered the National Phase

  PCT publication WO2011/123468 Priority application(s): WO2011/123468

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011235286-Systems and methods of providing foot operated latching

2011235267-Cases and covers for electronic handheld devices